OSUR

OraSure Technologies Inc

NASDAQ

Add Alert

OSUR

OraSure Technologies Inc

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

PennyWorld PremiumMember

01/26/24 11:04 PM

Post #369

Wow. Clay Trader sure blew that call on 10/19/20.

Going forward... Zacks has OSUR on it's "Buy" list for stocks under 10 bucks. That's a good sign.

paulsbest

01/21/21 6:19 AM

Post #368

Re: #367: @paulsbest - OraSure’s Oragene®•Dx Saliva Collection Kit Included in Industry’s

Industry’s First FDA Authorization

Unique, POS now. Imho

paulsbest

01/21/21 6:16 AM

Post #367

OraSure’s Oragene®•Dx Saliva Collection Kit Included in Industry’s First FDA Authorization for a Whole Exome Sequencin...

Read the news here

$$$ GLTA $$$

ClayTrader Free

10/19/20 5:30 PM

Post #366

* * $OSUR Video Chart 10-19-2020 * *

Link to Video - click here to watch the technical chart video

whytestocks Free

10/19/20 2:45 PM

Post #365

JUST IN: $OSUR Why OraSure Technologies Stock Is Soaring Today

Shares of OraSure Technologies (NASDAQ: OSUR) were soaring 15.2% as of 11:09 a.m. EDT on Monday. The big jump came after the company announced that the Food and Drug Administration granted Emergency Use Authorization (EUA) for the OMNIgene ORAL saliva collection and stabilization de...

Got this from OSUR - Why OraSure Technologies Stock Is Soaring Today

whytestocks Free

10/19/20 2:15 PM

Post #364

Just In: $OSUR OraSure's OMNIgene®·ORAL Collection Device Receives FDA Emergency Use Authorization for SARS CoV-2

BETHLEHEM, Pa., Oct. 19, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its DNA Genotek subsidiary has received Emergency Use Auth...

Read the whole news OSUR - OraSure's OMNIgene®·ORAL Collection Device Receives FDA Emergency Use Authorization for SARS CoV-2

JMMatthews Free

10/19/20 10:02 AM

Post #363

https://www.globenewswire.com/news-release/2020/10/19/2110238/0/en/OraSure-s-OMNIgene-ORAL-Collection-Device-Receives-FDA-Emergency-Use-Authorization-for-SARS-CoV-2.html

OSUR $$$

JMMatthews Free

09/11/20 9:42 AM

Post #362

Saw this on CBS news last night for rapid saliva test covid players

OSUR $$$

TFMG

08/25/20 9:27 AM

Post #361

$OSUR | #Orasure Tech Reversal Trade

The stock has retraced and bounced perfectly of the Fibonacci Golden pockets once again.
Fridays seen increased volume and bullish price action.
50 & 100 Moving Averages support once again
Alert set for break above $15.25 for long into huge gap.
Stochastic and RS bottomed and reversing.
Speculative and high risk
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.

purple_tree Free

05/20/20 1:59 PM

Post #360

purple_tree Free

05/20/20 1:59 PM

Post #359

UBS Virtual Global Healthcare Conference

Looks like good things ahead, recording can be accessed below

https://event.webcasts.com/starthere.jsp?ei=1309729&tp_key=b56dfb64ac

Stockholder meeting was pretty uneventful.

HokieHead

05/14/20 4:37 PM

Post #358

Looking forward to the stockholder meeting (video) on the 19th. I'm set!

HokieHead

05/12/20 8:26 AM

Post #357

More nice news this AM. This biotech is turning in to a beast. In since $11 area and dollar costing the whole way up for long term portfolio.

OraSure Technologies, Inc. Consolidates Microbiome Services Subsidiaries
May 12 2020 - 08:00AM GlobeNewswire Inc.

OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that its Diversigen and CoreBiome subsidiaries have combined their microbiome service offerings under the Diversigen name. The rebrand highlights the combined companies’ unparalleled scientific bench strength, state-of-the-art laboratory, ability to translate data to insights and collective focus on quality and service.
The unified Diversigen operation will continue to offer the science-driven, customized solutions for metagenomics sequencing, bioinformatics, and statistical analysis for the study of the microbiome for which CoreBiome and Diversigen are known. The unification elevates Diversigen as the cornerstone brand for microbiome services in the industry.

The combined organization includes scientific experts representing more than a century of microbiome experience and over 300 articles in respected scientific publications with more than 100,000 citations.

“The new Diversigen brand reflects the combined strength and innovation of these two microbiome service pioneers and positions the OraSure family of companies as an industry leader in this fast-growing industry. Together they will enable us to expand our services as we work to advance global health and bring our customers the tools, services and data-driven insights they need to get reliable, actionable answers to their most critical scientific and healthcare questions,” said Stephen S. Tang, Ph.D., President and Chief Executive Officer, OraSure Technologies, Inc.

All services previously offered under the CoreBiome brand will continue to be available from Diversigen, offering the microbiome market unparalleled choice in sequencing, bioinformatics and analysis services.

The rebrand was implemented after in-depth research, market analysis, and customer conversations. A new Diversigen logo will bring a sharp new visual identity, representing the best of both CoreBiome and Diversigen and characterizes the brand as smart, market-driven, and innovative.

The new Diversigen website is available at diversigen.com.

HokieHead

05/11/20 9:23 AM

Post #356

Mid 18's up pre-market. Easily 20's this week.

Possible 1 billion kits produced in 2021 and the company only valued at $1 billion. This is going a ton higher as it has been.

HokieHead

05/08/20 9:45 PM

Post #355

Article today, big things ahead for Orasure. 2021, possibly billions of units, that’s huge revenues..

OraSure President and CEO Stephen Tang said the company began considering developing a test as COVID-19 began spreading in January and February.

The company plans to develop a SARS-CoV-2 that, like its HIV test, will be suitable for home use and can provide results in under an hour, Tang said. He said the company aims to launch the product in September. Tang said that OraSure can currently manufacture about 13 million tests per year.

He noted, however, that some official plans to safely reopen the economy call for a billion tests per year.

"We're going to have to find a way to massively scale up," he said. "We're looking to design massive manufacturing of this from the start. Our job is to find facilities and manufacturers and partners who can jump in quickly to that manufacturing environment."

He said he anticipated being able to reach "full-scale manufacturing sometime in 2021," with a target of "tens of millions to a billion units per year."

https://www.modernhealthcare.com/technology/rapid-antigen-assays-could-prove-key-addressing-sars-cov-2-testing-limitations

HokieHead

05/08/20 11:01 AM

Post #354

This clearly is trading like a buyout is coming imo...

HokieHead

05/07/20 8:48 PM

Post #353

Re: #352: @purple_tree - https://www.globenewswire.com/news-release/2020/05/06/2028785/0/en/OraSure-Annou

Nice end of day buying, heading for $20+ next week imo. Great months ahead.

purple_tree Free

05/06/20 10:27 PM

Post #352

https://www.globenewswire.com/news-release/2020/05/06/2028785/0/en/OraSure-Announces-2020-First-Quarter-Financial-Results-and-Provides-COVID-19-Update.html

kairos

05/06/20 11:30 AM

Post #351

Re: #350: @HokieHead - 52 week high again, $20's coming.

strong day here ... OSUR

HokieHead

05/06/20 10:52 AM

Post #350

52 week high again, $20's coming.

HokieHead

05/05/20 9:19 PM

Post #349

Re: #348: @kairos - putting in a solid base here chart wise

Earnings and conference call tomorrow. News today was pretty good too.

kairos

05/04/20 7:55 AM

Post #348

Re: #347: @HokieHead - A daily double here. Their part of Biocerna’s

putting in a solid base here chart wise ... OSUR

HokieHead

05/04/20 7:53 AM

Post #347

Re: #346: @kairos - https://www.tradingview.com/x/z8p0aRCs/

A daily double here. Their part of Biocerna’s FDA nasal test and are creating a saliva test at home kit as well. $$ flowing in here. Looking forward to call this week.

kairos

05/04/20 7:35 AM

Post #346

HokieHead

05/04/20 7:30 AM

Post #345

Nice update! Big week ahead.

DNA Genotek Inc., a leading provider of sample collection kits and end-to-end services and a wholly-owned subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), announced today that its ORAcollect®·RNA kit (OR-100) was included as the collection device for anterior nares (nasal) samples under a U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) granted to Biocerna LLC for its PCR-based SARS-CoV-2 assay.

https://www.streetinsider.com/dr/news.php?id=16824757&gfv=1

HokieHead

05/02/20 9:44 AM

Post #344

Conference call Wednesday and I’m sure an update this week on the rapid home CV saliva testing kits. My guess we will be over $20 by Friday.

HokieHead

04/30/20 10:37 AM

Post #343

Beast...eom

HokieHead

04/29/20 4:24 PM

Post #342

Nice day again today, back over $16 tomorrow imo.

HokieHead

04/28/20 10:08 PM

Post #341

Re: #340: @purple_tree - First post, it is quiet here. Got excited

$16 will be cheap, by mid May this will be well in to the $20s, add in an approval for home test kits easily in the $30s.

https://www.inquirer.com/business/phillydeals/coronavirus-tang-orasure-saliva-testing-fda-20200418.html

purple_tree Free

04/28/20 9:58 PM

Post #340

Re: #337: @kairos - Looks like another nice find HH. I

First post, it is quiet here. Got excited when I read about them, but entered a little high ($16) Hopefully patience will be rewarded.

kairos

04/24/20 10:08 AM

Post #339

Re: #338: @HokieHead - Good to see you here, as you can

thanks ... I will slowly accumulate on any dips now. Love this share structure

OraSure Technologies, Inc.

Shares Outstanding
62,748,100

Float
62,133,357

Insider Ownership
1.30%

Insitutional Ownership
95.70%

HokieHead

04/24/20 10:05 AM

Post #338

Re: #337: @kairos - Looks like another nice find HH. I

Good to see you here, as you can see is trending higher. They will be a few billion dollar market cap company by the end of the summer.

kairos

04/24/20 9:24 AM

Post #337

Re: #336: @HokieHead - Been alone here for weeks, happy as a

Looks like another nice find HH. I hate to chase but did get a starter pre-market here

HokieHead

04/24/20 7:36 AM

Post #336

Been alone here for weeks, happy as a peach. Entry at $11.23 on the mother lode company of the home self CV test kits still has a long way to go. Hasn’t even been announced yet. $20s here next week.

HokieHead

04/20/20 9:14 PM

Post #335

Saliva testing mentioned on MSNBC tonight as the only way to get the country opened up again the right way. Trump mentioned there’s a game changing test about to be announced in a few weeks, OSUR continues to make new highs daily and has the at home saliva test to get it done. Should be an interesting few weeks here going forward if there’s any connection.

HokieHead

04/19/20 7:50 AM

Post #334

Back to $20s+ coming. Great weekend article..

U.S. grant speeds this Pa. coronavirus test to market this year
Updated: April 18, 2020 - 5:21 AM

https://www.inquirer.com/business/phillydeals/coronavirus-tang-orasure-saliva-testing-fda-20200418.html

HokieHead

04/17/20 7:37 AM

Post #333

Re: #332: @HokieHead - An in-home coronavirus test is being developed in

This will be a huge hit, rapid in-home testing, which will ease the burden on lab-based testing and folks don’t have to leave the house for test and results.

Company continues to make new highs daily. Still more good news on the way.

HokieHead

04/16/20 10:43 AM

Post #332

An in-home coronavirus test is being developed in Bethlehem. And the feds are backing it.

Updated Apr 06, 2020; Posted Apr 06, 2020

OraSure Technologies, the Bethlehem-based tech company that gained notoriety years ago with its rapid HIV test, has been awarded a $710,310 federal contract to develop an in-home coronavirus test, the company announced Monday morning.

The contract comes from the Biomedical Advanced Research and Development Authority, a division of the U.S. Department of Health and Human Services. It will enable OrasSure to file for special authorization from the FDA allowing the in-home test to debut in the U.S. market.

OraSure is billing the test’s development as a possible breakthrough in the fight against the coronavirus pandemic.

Once its developed and the necessary approvals are obtained, the test would help alleviate the pressure on over-burdened healthcare systems, a news release from OraSure says.

“Healthcare providers, retailers, and online vendors could ship tests directly to an individual’s home, eliminating unnecessary trips to hospitals, doctors’ offices, and testing facilities,” the release says. “This would help maintain social distancing and curb the spread of coronavirus through symptomatic and asymptomatic transmission. Rapid in-home testing could also ease the burden on lab-based testing.”

HokieHead

04/15/20 3:32 PM

Post #331

Ticker keeps hitting new highs and is in the rapid testing via saliva CV-19 testing. Looks like a winner from here imo. FDA approval for in-home test news any day now imo.

-The diagnostic test company said it plans to file for FDA Emergency Use Authorization allowing for an in-home self-test to debut into the U.S. market.

-OraSure said its portable rapid test platform uses an oral fluid sample and provides results in 20 minutes, with no instrumentation or trained personnel needed to administer the test or read the results.

-Co announced it has been awarded a $710,310 contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Department of Health and Human Services (HHS), to develop a pan-SARS-coronavirus antigen rapid in-home self-test that uses oral fluid samples. This support from BARDA will enable OraSure to file for FDA Emergency Use Authorization (EUA) allowing for an in-home self-test to debut into the U.S. market.

XenaLives

02/21/20 7:53 AM

Post #330

Security OSUR / OraSure Technologies, Inc. (68554V108)
President and CEO TANG STEPHEN S PHD
ISIN US68554V1089
Industry Surgical and Medical Instruments and Apparatus
Institutional Owners 401
Institutional Shares 58,419,785 - 94.70%
Common Shares Outstanding 61,687,392 shares (as of 2019-03-31)
Institutional Value $ 1,736,356 USD

https://fintel.io/so/us/osur